AN2 <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc. Executes Share Exchange Agreements with Coastlands Capital, Issuing Pre-Funded Warrants for 2.8 Million Shares
AN2 Therapeutics Inc. has engaged in share transactions with Coastlands Capital Partners LP. On June 17, 2025, Coastlands Capital exchanged 2,500,000 shares of the company's common stock for a pre-funded warrant to acquire an equivalent number of shares. Similarly, on June 19, 2025, 300,000 shares of common stock were exchanged for a pre-funded warrant to acquire 300,000 shares. The pre-funded warrants have an exercise price of $0.00001 per share and are exercisable at any time until fully exercised.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-143187), on June 20, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。